FI960353A0 - Ihmisen interleukiini-10:n agonistit ja antagonistit - Google Patents

Ihmisen interleukiini-10:n agonistit ja antagonistit

Info

Publication number
FI960353A0
FI960353A0 FI960353A FI960353A FI960353A0 FI 960353 A0 FI960353 A0 FI 960353A0 FI 960353 A FI960353 A FI 960353A FI 960353 A FI960353 A FI 960353A FI 960353 A0 FI960353 A0 FI 960353A0
Authority
FI
Finland
Prior art keywords
agonists
antagonists
human interleukin
interleukin
human
Prior art date
Application number
FI960353A
Other languages
English (en)
Swedish (sv)
Other versions
FI960353A (fi
Inventor
Chuan-Chu Chou
Xiao-Yan Cai
Original Assignee
Schering Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Schering Corp filed Critical Schering Corp
Publication of FI960353A0 publication Critical patent/FI960353A0/fi
Publication of FI960353A publication Critical patent/FI960353A/fi

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09Recombinant DNA-technology
    • C12N15/11DNA or RNA fragments; Modified forms thereof; Non-coding nucleic acids having a biological activity
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K14/00Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/52Cytokines; Lymphokines; Interferons
    • C07K14/54Interleukins [IL]
    • C07K14/5428IL-10
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00Medicinal preparations containing peptides
    • A61K38/16Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/19Cytokines; Lymphokines; Interferons
    • A61K38/20Interleukins [IL]
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K14/00Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/52Cytokines; Lymphokines; Interferons
    • C07K14/54Interleukins [IL]
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00Medicinal preparations containing peptides
    • YGENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02ATECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Genetics & Genomics (AREA)
  • Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Zoology (AREA)
  • Molecular Biology (AREA)
  • Medicinal Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Biomedical Technology (AREA)
  • Biophysics (AREA)
  • Biochemistry (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Toxicology (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Wood Science & Technology (AREA)
  • General Engineering & Computer Science (AREA)
  • Biotechnology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Epidemiology (AREA)
  • Physics & Mathematics (AREA)
  • Immunology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Plant Pathology (AREA)
  • Microbiology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Peptides Or Proteins (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
FI960353A 1993-07-26 1996-01-26 Ihmisen interleukiini-10:n agonistit ja antagonistit FI960353A (fi)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US9894393A 1993-07-26 1993-07-26
PCT/US1994/008052 WO1995003411A1 (en) 1993-07-26 1994-07-22 Agonists and antagonists of human interleukin-10

Publications (2)

Publication Number Publication Date
FI960353A0 true FI960353A0 (fi) 1996-01-26
FI960353A FI960353A (fi) 1996-01-26

Family

ID=22271670

Family Applications (1)

Application Number Title Priority Date Filing Date
FI960353A FI960353A (fi) 1993-07-26 1996-01-26 Ihmisen interleukiini-10:n agonistit ja antagonistit

Country Status (17)

Country Link
EP (1) EP0711346A1 (fi)
JP (1) JPH08507930A (fi)
KR (1) KR960704041A (fi)
CN (1) CN1127529A (fi)
AU (1) AU681178B2 (fi)
CA (1) CA2168110A1 (fi)
CZ (1) CZ23396A3 (fi)
FI (1) FI960353A (fi)
HU (1) HUT73463A (fi)
IL (1) IL110413A0 (fi)
NO (1) NO960309L (fi)
NZ (1) NZ269663A (fi)
PL (1) PL312718A1 (fi)
SG (1) SG43798A1 (fi)
SK (2) SK150596A3 (fi)
WO (1) WO1995003411A1 (fi)
ZA (1) ZA945434B (fi)

Families Citing this family (26)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CZ1497A3 (en) 1994-07-05 1997-05-14 Steeno Res Group As Polypeptide, its use and pharmaceutical composition based thereon, a nucleotide sequence and antibody
GB2304047A (en) 1995-08-09 1997-03-12 Univ Manchester Pharmaceutical compositions containing cytokines
AUPN481295A0 (en) * 1995-08-16 1995-09-07 Medvet Science Pty. Ltd. Agonists of haemopoietic growth factors
AU4385696A (en) 1996-01-18 1997-08-11 Christian Gronhoj Larsen Synthetic il-10 analogues
DE19851675A1 (de) * 1998-11-10 2000-05-11 Bayer Ag Menschliche Interleukin-10 Mutantenproteine
EP1283722A1 (en) 2000-03-31 2003-02-19 Idec Pharmaceuticals Corporation Combined use of anti-cytokine antibodies or antagonists and anti-cd20 for the treatment of b cell lymphoma
WO2002026265A2 (en) 2000-09-29 2002-04-04 Schering Corporation Pegylated interleukin-10
US7261882B2 (en) 2003-06-23 2007-08-28 Reagents Of The University Of Colorado Methods for treating neuropathic pain by administering IL-10 polypeptides
EP1712241A1 (en) 2005-04-15 2006-10-18 Centre National De La Recherche Scientifique (Cnrs) Composition for treating cancer adapted for intra-tumoral administration and uses thereof
EP2816118B1 (en) 2005-05-31 2018-10-17 The Regents of the University of Colorado, a body corporate Methods for delivering genes
NO346530B1 (no) 2006-09-28 2022-09-26 Merck Sharp & Dohme Anvendelser av pegylert interleukin-10 (PEG-IL-10) for å forebygge metastaser av kreft eller tumor i lungene.
PT2344540T (pt) * 2008-10-02 2018-02-02 Aptevo Res & Development Llc Proteínas de ligação multi-alvo antagonistas de cd86
ES2655364T3 (es) 2008-12-17 2018-02-19 Merck Sharp & Dohme Corp. Producción de IL-10 mono- y dipegilada y sus usos
PL2776460T3 (pl) 2011-11-08 2018-10-31 Umc Utrecht Holding B.V. Białko fuzyjne zawierające interleukinę 4 i interleukinę 10
US9943568B2 (en) 2013-04-18 2018-04-17 Armo Biosciences, Inc. Methods of using pegylated interleukin-10 for treating cancer
CA2908208A1 (en) * 2013-04-24 2014-10-30 Armo Biosciences, Inc. Interleukin-10 compositions and uses thereof
EP3010527B1 (en) 2013-06-17 2018-08-08 Armo Biosciences, Inc. Method for assessing protein identity and stability
EP3038642A4 (en) 2013-08-30 2017-01-18 Armo Biosciences, Inc. Methods of using interleukin-10 for treating diseases and disorders
WO2015070060A1 (en) 2013-11-11 2015-05-14 Armo Biosciences, Inc. Methods of using interleukin-10 for treating diseases and disorders
US10293043B2 (en) 2014-06-02 2019-05-21 Armo Biosciences, Inc. Methods of lowering serum cholesterol
MX2017004838A (es) 2014-10-14 2017-10-16 Armo Biosciences Inc Composiciones de interleucina-15 y usos de estas.
US10143726B2 (en) 2014-10-22 2018-12-04 Armo Biosciences, Inc. Methods of using interleukin-10 for treating diseases and disorders
WO2016126615A1 (en) 2015-02-03 2016-08-11 Armo Biosciences, Inc. Methods of using interleukin-10 for treating diseases and disorders
KR20180020141A (ko) 2015-05-28 2018-02-27 아르모 바이오사이언시스 인코포레이티드 암 치료에 사용되는 peg화된 인터류킨-10
WO2017035232A1 (en) 2015-08-25 2017-03-02 Armo Biosciences, Inc. Methods of using interleukin-10 for treating diseases and disorders
GB2620875B (en) 2019-04-19 2024-05-08 Synerkine Pharma B V A fusion protein comprising IL13

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH01113229A (ja) * 1987-10-27 1989-05-01 Inahata Kenkyusho:Kk 多孔質ハニカム構成材
IL94878A (en) * 1989-06-28 2003-01-12 Schering Corp Cytokine synthesis inhibitory factor, antagonists thereof and methods of using same
DK0600970T3 (da) * 1991-08-06 2000-05-29 Schering Corp Anvendelse af interleukin-10-analoger eller -antagonister til behandling af endotoksin- eller superantigeninduceret tokscit

Also Published As

Publication number Publication date
AU7399694A (en) 1995-02-20
NO960309D0 (no) 1996-01-25
NZ269663A (en) 1997-09-22
JPH08507930A (ja) 1996-08-27
SK150596A3 (en) 1997-04-09
CA2168110A1 (en) 1995-02-02
WO1995003411A1 (en) 1995-02-02
HUT73463A (en) 1996-08-28
IL110413A0 (en) 1994-10-21
ZA945434B (en) 1995-01-23
AU681178B2 (en) 1997-08-21
EP0711346A1 (en) 1996-05-15
SG43798A1 (en) 1997-11-14
SK8396A3 (en) 1997-03-05
PL312718A1 (en) 1996-05-13
FI960353A (fi) 1996-01-26
KR960704041A (ko) 1996-08-31
CN1127529A (zh) 1996-07-24
CZ23396A3 (en) 1996-05-15
NO960309L (no) 1996-01-25
HU9503983D0 (en) 1996-03-28

Similar Documents

Publication Publication Date Title
FI960353A0 (fi) Ihmisen interleukiini-10:n agonistit ja antagonistit
BR8901779A (pt) Absorvente higienico e metodo de aplicacao do mesmo
KR890700608A (ko) 사람 인터루킨-3 및 이의 뮤테인
DE69315855D1 (de) Untersuchung von wiederkäuern
DE69406116D1 (de) Reinigungszusammensetzung und verwendungsverfahren
BR8903526A (pt) Composicao de lubrificantes e aplicacao
FI901489A0 (fi) Anordning foer i en roerformig ledning utfoerd fjaerrstyrd roerelse.
ES292142Y (es) Dispositivo de montaje de protesis oseas y similares
BR8801089A (pt) Utilizacao de sistemas,sistemas e compostos
EE9700209A (et) Dihüdropürimidiinid ja nende kasutamine
DK609689A (da) Folielaminat og dets anvendelse
EE03901B1 (et) Elastne vaheriie ja selle kasutamine
FI965204A (fi) Bromelaiinin lääkekäyttö
PT87554A (pt) Didinfecting and sterilizing composition
FI945427A0 (fi) Dynemisiinianalogien enantiomeerit, niiden valmistus ja käyttö
BR8805425A (pt) Composicao de organopolissiloxano e utilizacao da mesma
NO174731C (no) Anti-mikrobiell blanding og anvendelse derav
AU3681795A (en) Polypeptide agonists and antagonists of human interleukin-8
BR8905444A (pt) Composicoes e aplicacao
BR8805426A (pt) Composicao de organopolissiloxano e utilizacao da mesma
BR9306359A (pt) Azocorantes aplicação do azocorante e modificação cristalina
FI963263A0 (fi) Bromelaiinin lääkinnällinen käyttö
BR8806983A (pt) Composicao de pintura e aplicacao
DK285288A (da) Peptid og dets anvendelse
FI945493A (fi) Ti (III)-pitoisen liuoksen valmistus ja sen käyttö